Cannabinoides…
575
11. Ben Amar, M. Cannabinoids in medicine: A review of their therapeutic potential.
J
Ethnopharmacol , 105 (1-‐2), 1-‐25 (2006).
12. Hosking, R. D.; Zajicek, J. P. Therapeutic potential of cannabis in pain medicine. Br J Anaesth
101 (1), 59-‐68 (2008).
13. Pandey, R.; Mousawy, K.; Nagarkatti, M.; Nagarkatti, P. Endocannabinoids and immune
regulation. Pharmacol Res, 60 (2), 85-‐92 (2009).
14. Thakur, G. A.; Duclos, R. I. Jr; Makriyannis, A. Natural cannabinoids: templates
15. Matias, I. ; Di Marzo, V. Endocannabinoid synthesis and degradation, and their regulation in
the framework of energy balance. J Endocrinol Invest, 29, 15-‐26. (2006).
16. Piomelli, D.; Giuffrida A. ; Calignano, A.; Rodríguez de Fonseca, F. The endocannabinoid
system as a target for therapeutic drugs. Trends Pharmacol Sci, 21 (6), 218-‐224 (2000).
17. Felder, C.C.; Dickason-‐Chesterfield, A.K.; Moore, S. A. Cannabinoids biology: the search for
new therapeutic targets. Mol Interv, 6 (3), 149-‐161.
18. McFarland, M.J.; Barker, E.L. Anandamide transport. Pharmacol Ther, 104 (2), 117-‐135
(2004).
19. Guzmán, M.; Sánchez, C.; Galve-‐Roperh, I.Control of the cell survival/death by
cannabinoids. J Mol Med (Berl), 78 (11), 613-‐625 (2001).
20. Hirst, R. A.; Lambert, D. G.; Notcutt, W. G. Pharmacology and potential therapeutic uses of
cannabis. Br J Anaesth, 81 (1), 77-‐84 (1998).
21. McAllister, S. D.; Glass, M. CB1 and CB2 receptor-‐mediated signalling: a focus on
endocannabinoids. Prostaglandins Leukot Essent Fatty Acids, 66 (2-‐3), 161-‐171 (2002).
22. Fine, P. G.; Rosenfeld, M. J. The endocannabinoid system, cannabinoids, and pain. Rambam
Maimonides Med J, 4 (4), 1-‐15 (2013).
23. Velasco, G; Galve-‐Roperh, I.; Sánchez, C.; Blázquez, C.; Guzmán, M. Hypothesis: cannabinoid
therapy for the treatment of gliomas ?. Neuropharmacology, 47 (3), 315-‐323 (2004).
24. Velasco, G.; Galve-‐Roperh, I.; Sánchez C, Blázquez, C.; Haro, A.; Guzmán, M. Cannabinoids
and ceramide: two lipids acting hand-‐by-‐hand. Life Sci, 77 (14), 1723-‐1731 (2005).
25. Munro, S.; Thomas, K. L.; Abu-‐Shaar, M. Molecular characterization of a peripheral receptor
for cannabinoids. Nature, 365 (6441), 61-‐65 (1993).
26. Herkenham, M.; Lynn, A. B.; Johnson, M. R.; Melvin, L.S.; De Costa, B. R.; Rice, K.C.
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in
vitro autoradiographic study. J Neurosci, 11 (2), 563-‐583 (1991).
27. Henstridge, C.M.; Balenga, N. A.; Kargl, J.; Andradas, C.; Brown, A. J.; Irving, A.; Sanchez, C.;
Waldhoer, M. Minireview: Recent Developments in the Physiology and Pathology of the
Lysophosphatidylinositol-‐Sensitive Receptor GPR55. Mol Endocrinol, 25 (11), 1835:1848
(2011)
28. Sylantyev, S.; Jensen; T. P.; Ross, R. A.; Rusakov, D. A. Cannabinoid and
lysophosphatidylinositol sensitive receptor GPR55 boosts neurotransmitter release at
central synapses. Proc Natl Acad Sci USA, 110 (13), 5193-‐5198 (2013).
29. Izzo, A. A.; Borrelli, F.; Capasso, R.; Di Marzo, V.; Mechoulam, R.Non-‐psychotropic plant
cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol
Sci, 30 (10), 515-‐527 (2009).
30. Henstridge, C. M. Off target cannabinoid effects mediated by GPR55. Pharmacology, 89 (3-‐
4), 179-‐187 (2012).
31. Ryberg, E.; Larsson, N.; Sjögren, S.; Hjorth, S.; Hermansson, N. O.; Leonova, J.; Elebring, T.;
Nilsson, K.; Drmota, T.; Greasley, P. J. The orphan receptor GPR55 is a novel cannabinoid
receptor. Br J Pharmacol, 152 (7), 1092-‐1101 (2007).
32. Tominaga, M.; Tominaga, T. Structure and function of TRPV. Pflugers Arch, 451 (1), 143-‐
150 (2005).
33. Kola, B.; Boscaro, M.; Rutter, G. A.; Grossman, A. B.; Korbonitis, M. Expanding role of AMPK
in endocrinology. Trends Endocrinol Metab, 17 (5), 205-‐215 (2006).
34. Van Thuijl, H.; Kola, B.; Korbonits, M. Appetite and metabolic effects of ghrelin and
cannabinoids: involvement of AMPactivated protein kinase. Vitam Horm, 77, 121-‐148
(2008).
35. Porter, A. C.; Felder, C. C. The endocannabinoid nervous system: Unique opportunities for
therapeutic intervention. Pharmacol Ther, 90 (1), 45-‐60 (2001).
36. Solinas, M.; Goldberg, S. R.; Piomelli, D. The endocannabinoid system in brain reward
processes. Br J Pharmacol, 154 (2), 369-‐383 (2008).
